drugset
drugset / Trial / NCT04451330

A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)

NCT04451330 ↗

Phase 4 Completed 202 enrolled Galderma R&D
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study was to demonstrate that daily use of topical trifarotene (CD5789) 50 microgram per gram (mcg/g) cream when used in association with oral antibiotic is safe and effective for the treatment of severe AV.

Timeline

Start
2020-07-29
Primary completion
2021-04-26
Completion
2021-04-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline hyclate Small molecule 120 mg Oral
Subject Trifarotene Small molecule 50 unknown Topical

Indications

acne